Pregnancy safety after taking nifurtimox
Part of Infections clinical trials.
This study follows women who took the medicine nifurtimox during pregnancy to watch for any complications and to check the health of both mother and baby afterward. It does not give you any new medicine, just tracks what happens.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female and took at least one dose of the medicine nifurtimox while pregnant.
- If you are under 18, you agree to take part and your parent or guardian agrees to let you join.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a shorter course of benznidazole (a medicine for Chagas disease) to the standard longer treatment. It aims to see if the shorter regimen works as well and is safe for people with confirmed Chagas infection.
This trial tests a new drug called LXE408 for people with chronic Chagas disease. It aims to see if the drug is safe and effective, and participants will also receive standard treatment with benznidazole.
This trial is testing new rapid diagnostic tests to detect infection with Trypanosoma cruzi, which causes Chagas disease. It aims to find faster ways to diagnose people who may be at risk, such as pregnant women, blood donors, or those with possible chronic infection.
This trial tests if a common antibiotic can safely treat bacteria in the urine of pregnant women who have no symptoms, to see if it prevents later infections. It focuses on women in low- and middle-income countries.
This study tests a medicine given to mothers after childbirth to see how it passes into breast milk and if it is safe for babies. It may help prevent malaria relapse in mothers who have had vivax malaria.
This study follows people who took mavacamten during pregnancy or breastfeeding to better understand infant outcomes. It may help doctors and families know what to expect and improve safety guidance.
Hear when a new Chagas Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.